Carey School of Business Announces Summer Commencement Speaker
The Carey School of Business has announced that Tony Coles, MD, will deliver the commencement address at this summer’s graduation ceremony. The ceremony will be held on Tuesday, August 9, 2016, at the Joseph Meyerhoff Symphony Hall in Baltimore, Maryland.
Dr. Coles is a founding investor and chairman and chief executive officer of Yumanity Therapeutics, a company focused on transforming drug discovery for neurodegenerative diseases like Alzheimer’s, Parkinson’s and amyotrophic lateral sclerosis (ALS). He also serves as chairman and chief executive officer for the privately held company TRATE Enterprises.
Bernie Ferrari, dean of the Carey Business School said in a statement,
“Tony Coles is a business leader who is working to find solutions to some of our greatest health care challenges. He exemplifies what it means to practice business with humanity in mind and we are very pleased to have him as our commencement speaker.”
Dr. Coles currently serves on the board of CRISPR Therapeutics, a biopharmaceutical company focused on developing transformative gene-based medicines for patients with serious diseases. He is also actively involved at Johns Hopkins University, sitting as vice chair of the board of trustees and a member of the board of trustees for Johns Hopkins Medicine. He received his undergraduate degree at Johns Hopkins University before earning his medical degree from Duke University. He also has a master’s degree in public health from Harvard University.
As previously announced, David M. Rubenstein, the co-founder and co-chief executive officer of The Carlyle Group, will deliver a graduation address at the Carey Business School’s spring commencement on May 17, 2016.
Ferrari had the following to say about Rubenstein when the announcement was made,
“Mr. Rubenstein is a very successful business leader and exemplary citizen with a longstanding commitment to higher education. He has served as an emeritus member of the Johns Hopkins University board of trustees, and he is a current member of the Johns Hopkins Medicine board of trustees, as well as many other boards. I know our graduates will benefit from his insights.”
About the Author
Max Pulcini
Max Pulcini is a Philadelphia-based writer and reporter. He has an affinity for Philly sports teams, Super Smash Bros. and cured meats and cheeses. Max has written for Philadelphia-based publications such as Spirit News, Philadelphia City Paper, and Billy Penn, as well as national news outlets like The Daily Beast.
